185 related articles for article (PubMed ID: 7203382)
1. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
Nishida K; Yoshikawa T; Kondo M; Thiele HG
Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
Nishida K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
[TBL] [Abstract][Full Text] [Related]
4. CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure.
Farini R; Nitti D; Del Favero G; Rossi CR; Costantin G; Rebuffi A; Farini A; Piccoli A; Matarazzo R; Lise M; Naccarato R
Hepatogastroenterology; 1980 Jun; 27(3):213-6. PubMed ID: 7461595
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of pancreatic cancer by pancreatic oncofetal antigen (poa) in pure pancreatic juice.
Nishida K; Kondo M; Jessen K; Classen M
Hepatogastroenterology; 1981 Apr; 28(2):102-5. PubMed ID: 7216142
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
8. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
9. Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer.
Tatsuta M; Yamamura H; Yamamoto R; Okano Y; Morii T; Okuda S; Tamura H
Cancer; 1983 Nov; 52(10):1880-5. PubMed ID: 6627206
[TBL] [Abstract][Full Text] [Related]
10. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin in pure pancreatic juice.
Nicolai JJ; Teunen A; Zuyderhoudt F; Hoek F; Tytgat GN
Scand J Gastroenterol; 1984 Sep; 19(6):765-9. PubMed ID: 6440270
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic juice protein associated with chronic pancreatitis and adenocarcinoma of the pancreas.
Schneider MU; Rösch W; Domschke S; Domschke W
Scand J Gastroenterol; 1984 Mar; 19(2):139-44. PubMed ID: 6719028
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma.
Nazli O; Bozdag AD; Tansug T; Kir R; Kaymak E
Hepatogastroenterology; 2000; 47(36):1750-2. PubMed ID: 11149048
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
[TBL] [Abstract][Full Text] [Related]
18. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
Takada S; Hoshi H; Ito F; Imai K; Yachi A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1487-91. PubMed ID: 6378102
[TBL] [Abstract][Full Text] [Related]
19. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
